MetaCap

BridgeBio Oncology Therapeutics Statistics

NASDAQ: BBOTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.81-0.05 (-2.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BridgeBio Oncology Therapeutics by the numbers

BridgeBio Oncology Therapeutics has a market capitalization of $145.3 million based on 80.25M shares outstanding. Its trailing P/E ratio is 3.4. The stock trades 42.3% below its 50-day average and 75.5% below its 200-day average.

Average daily trading volume is 631.56K shares, or about $1.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BBOT valuation vs. peer median

BBOT compared with the median of 8 peer companies
MetricBBOTPeer medianDifference
Market cap$145.25M$148.17M-2%
Avg. volume631.56K831.15K-24%

Peer median across 8 companies: PRQR, VRXA, RNA, ELDN, IFRX, ALXO, ORMP, ZNTL.

Valuation

Price and trading

Previous close
1.86
Open
1.87
Day range
1.79 – 1.94
52-week range
1.79 – 14.87
52-week change
-85.39%
Beta
—
Volume
450.96K

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
145.25M
Pe
3.42
Forward Pe
-0.87
Eps
0.53
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
14.87
Week52 Low
1.79
Avg Volume
631.56K
Shares Outstanding
80.25M
Ma50
3.14
Ma200
7.40
Earnings Date
Nov 10, 2026
Pct From52w High
-87.83%
Pct From52w Low
1.40%

Related